CASI Pharmaceuticals (CASI) PT Lowered to $10 at BTIG
Tweet
Share
E-mailGet Alerts CASI Hot Sheet
Price: $0.21 --0%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Join SI Premium – FREE
BTIG analyst Justin Zelin lowered the price target on CASI Pharmaceuticals (NASDAQ: CASI) to $10.00 (from $21.00) while maintaining a Buy rating.
You May Also Be Interested In
- Enhanced Group Inc. (ENHA) PT Lowered to $5 at Canaccord
- Quanterix Corp. (QTRX) PT Lowered to $3 at Canaccord
- Veeva Systems (VEEV) PT Raised to $275 at Stifel on Expected Q2 Outperformance
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
